Total Funding
56
51
Total FundingSeed raised
Growth Score 56 in past quarter
-20 pts
Heat Score 51 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33574
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
Chun-Hao Huang: CEO & Co-FounderPast Role: University of California Berkeley, Postdoc, CRISPR Gene-Editing
Jeffrey P. Whitten: Chief Scientific OfficerPast Role: Turning Point Therapeutics, SVP Preclinical and CMC Development
About the Company
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks. The company is based in San Francisco, California, United States.